Related Experiment Video
Updated: Jun 2, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
A novel knock-in mouse reveals mechanistically distinct forms of morphine tolerance
Johan Enquist1, Joseph A Kim, Selena Bartlett
1Ernest Gallo Clinic and Research Center, 5858 Horton St., Emeryville, CA 94608, USA.
Abstract:
The role of μ-opioid receptor (MOR) down-regulation in opioid tolerance remains controversial. In this study, we used a novel knock-in mouse to examine how changing the extent of MOR down-regulation alters the development of morphine tolerance. These mice express a mutant MOR, degrading MOR (DMOR), that differs from the wild-type (WT) MOR in two ways: 1) unlike the recycling WT MOR, the mutant DMOR is targeted for degradation after its internalization, thus facilitating down-regulation; and 2) unlike the WT MOR, DMOR is efficiently internalized in response to morphine activation. We found that both WT MOR and DMOR mice develop tolerance to morphine, but DMOR mice exhibit a more rapid onset of tolerance and show receptor down-regulation. WT MOR mice develop morphine tolerance more slowly but even once profoundly tolerant show no receptor down-regulation. Furthermore, WT mice show significantly more morphine dependence than DMOR mice after long-term treatment as indicated by withdrawal. Taken together these data indicate that tolerance mediated by receptor down-regulation manifests differently both at the behavioral and biochemical level than does the actual morphine tolerance that occurs in WT mice and that loss of receptor function is not a major contributor to morphine tolerance in WT MOR mice.
Insights
Investigating μ-opioid receptor (MOR) down-regulation in morphine tolerance, this study reveals that receptor degradation accelerates tolerance but reduces dependence. Wild-type MOR mice develop tolerance slower with less dependence and no receptor down-regulation.
Area of Science:
- Pharmacology
- Neuroscience
- Molecular Biology
Background:
- The role of μ-opioid receptor (MOR) down-regulation in the development of opioid tolerance is not fully understood.
- Existing research presents conflicting findings regarding the direct link between MOR down-regulation and the extent of opioid tolerance.
Purpose of the Study:
- To investigate how varying degrees of MOR down-regulation impact the development of morphine tolerance using a novel knock-in mouse model.
- To differentiate between tolerance mediated by receptor down-regulation and other mechanisms of morphine tolerance.
Main Methods:
- Generation of a novel knock-in mouse model expressing a mutant degrading MOR (DMOR) that is targeted for degradation upon internalization, unlike wild-type (WT) MOR.
- Comparative analysis of morphine tolerance, dependence, and MOR expression levels between WT MOR and DMOR mice after morphine administration.
- Assessment of receptor internalization and degradation following morphine activation in both WT and DMOR mice.
Main Results:
- DMOR mice exhibited a more rapid onset of morphine tolerance accompanied by significant MOR down-regulation compared to WT MOR mice.
- WT MOR mice developed morphine tolerance more slowly, and profound tolerance was observed without significant MOR down-regulation.
- WT MOR mice displayed significantly higher morphine dependence, indicated by withdrawal symptoms, after long-term treatment compared to DMOR mice.
Conclusions:
- Tolerance mediated by MOR down-regulation has distinct behavioral and biochemical manifestations compared to morphine tolerance in WT mice.
- Receptor down-regulation is not a primary contributor to morphine tolerance in WT MOR mice.
- Altering the extent of MOR down-regulation influences the development of morphine tolerance and dependence, suggesting distinct underlying mechanisms.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
In-vitro Mutagenesis

